These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2119889)

  • 1. Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals.
    Roux P; Blanchard JM; Fernandez A; Lamb N; Jeanteur P; Piechaczyk M
    Cell; 1990 Oct; 63(2):341-51. PubMed ID: 2119889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular distribution of the c-fos antigen during the cell cycle.
    Rahm M; Hultgårdh-Nilsson A; Jiang WQ; Sejersen T; Ringertz NR
    J Cell Physiol; 1990 Jun; 143(3):475-82. PubMed ID: 1694182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Elk-1 phosphorylation and dysregulation of the extracellular regulated kinase signaling pathway in senescent human fibroblast.
    Tresini M; Lorenzini A; Frisoni L; Allen RG; Cristofalo VJ
    Exp Cell Res; 2001 Oct; 269(2):287-300. PubMed ID: 11570821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
    Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes.
    Cohen DR; Ferreira PC; Gentz R; Franza BR; Curran T
    Genes Dev; 1989 Feb; 3(2):173-84. PubMed ID: 2497053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and viral Fos proteins are degraded by different proteolytic systems.
    Acquaviva C; Salvat C; Brockly F; Bossis G; Ferrara P; Piechaczyk M; Jariel-Encontre I
    Oncogene; 2001 Feb; 20(8):942-50. PubMed ID: 11314029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proto-oncogene fos: factors affecting expression and covalent modification of the gene product.
    Barber JR; Sassone-Corsi P; Verma IM
    Ann N Y Acad Sci; 1987; 511():117-30. PubMed ID: 2830821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myristylation alters DNA-binding activity and transactivation of FBR (gag-fos) protein.
    Kamata N; Jotte RM; Holt JT
    Mol Cell Biol; 1991 Feb; 11(2):765-72. PubMed ID: 1846672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. v-FBR-fos oncogene fails to rescue mammalian cells from growth arrest but affects the responses of human fibroblasts to heparin.
    Kolettas E; Evangelou A; Gonos ES
    Anticancer Res; 2001; 21(1A):435-44. PubMed ID: 11299775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum.
    Barber JR; Verma IM
    Mol Cell Biol; 1987 Jun; 7(6):2201-11. PubMed ID: 3110603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of nuclear oncoproteins by the ubiquitin system in vitro.
    Ciechanover A; DiGiuseppe JA; Bercovich B; Orian A; Richter JD; Schwartz AL; Brodeur GM
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):139-43. PubMed ID: 1846034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased susceptibility to calpains of v-FosFBR but not of v-FosFBJ or v-JunASV17 retroviral proteins compared with their cellular counterparts.
    Steff AM; Carillo S; Pariat M; Piechaczyk M
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):685-92. PubMed ID: 9169601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a murine monoclonal antibody that detects the fos oncogene product.
    Giardina SL; Evans SW; Gandino L; Robey FA; Bonvini E; Longo DL; Varesio L
    Anal Biochem; 1987 Feb; 161(1):109-16. PubMed ID: 3034094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific expression of mRNA in mouse lymphocytes detected by v-fos but not by human c-fos DNA probes.
    Kikuchi K; Makishima F
    Cell Struct Funct; 1990 Dec; 15(6):323-8. PubMed ID: 1982247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase.
    Sistonen L; Hölttä E; Lehväslaiho H; Lehtola L; Alitalo K
    J Cell Biol; 1989 Nov; 109(5):1911-9. PubMed ID: 2572601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the c-fos proto-oncogene in bone, cartilage and tooth forming tissues during mouse development.
    Caubet JF; Bernaudin JF
    Biol Cell; 1988; 64(1):101-4. PubMed ID: 3147115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
    Deng T; Karin M
    Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of c-Fos gene transcription with malignant transformation of human bronchial epithelial cells.
    Lee HY; Chaudhary J; Walsh GL; Hong WK; Kurie JM
    Oncogene; 1998 Jun; 16(23):3039-46. PubMed ID: 9662337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and purification of human fos protein generated in insect cells with a baculoviral expression vector.
    Tratner I; De Togni P; Sassone-Corsi P; Verma IM
    J Virol; 1990 Feb; 64(2):499-508. PubMed ID: 2104941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.